scispace - formally typeset
A

Adrian Avila

Researcher at University of Texas Southwestern Medical Center

Publications -  8
Citations -  60

Adrian Avila is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 2 publications receiving 47 citations.

Papers
More filters
Journal ArticleDOI

Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays

TL;DR: A method for the parallel analysis of multiple CpG sites in genomic DNA for their state of methylation and demonstrated this technique with a region from the promoter of the tumor suppressor gene p16, which is hypermethylated in many cancers.
Journal ArticleDOI

Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency

TL;DR: Electroencephalography in G1D individuals revealed nutrition time-dependent seizure oscillations often associated with preserved volition despite electrographic generalization and uniform average oscillation duration and periodicity, suggesting increased facilitation of an underlying neural loop circuit.
Journal ArticleDOI

Red blood cells as glucose carriers to the human brain: Modulation of cerebral activity by erythrocyte exchange transfusion in Glut1 deficiency (G1D)

TL;DR: In this article , the authors proposed a nearly direct pathway for metabolic substrate transfer to neural cells that complements the better characterized plasma to endothelium transfer, which was further substantiated by in vitro measurement of direct erythrocyte to endothelial cell glucose flux.
Journal ArticleDOI

Development and validation of a LC-MS/MS method for quantitation of 3-hydroxypentanoic acid and 3-oxopentanoic acid in human plasma and its application to a clinical study of glucose transporter type I deficiency (G1D) syndrome

TL;DR: In this paper, a liquid chromatography-tandem mass spectrometric method was proposed for the simultaneous quantitative determination of the ketone body byproducts 3-hydroxypentanoic acid and 3-oxopentanonic acid in plasma.
Journal ArticleDOI

Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D)

TL;DR: In this paper , a 3 + 3 dose-finding approach was used to establish a maximum, potentially greater dose of triheptanoin for Glucose transporter type 1 deficiency encephalopathy (G1D).